Comments
Loading...
G Medical Innovations Analyst Ratings and Price Targets | OTC:GMVDF | Benzinga
G Medical Innovations Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for G Medical Innovations Corp from these most-recent analyst ratings.
Analyst Ratings for G Medical Innovations
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for G Medical Innovations (GMVDF) stock?
There is no price target for G Medical Innovations
What is the most recent analyst rating for G Medical Innovations (GMVDF)?
There is no analyst for G Medical Innovations
When was the last upgrade for G Medical Innovations (GMVDF)?
There is no last upgrade for G Medical Innovations
When was the last downgrade for G Medical Innovations (GMVDF)?
There is no last downgrade for G Medical Innovations.
When is the next analyst rating going to be posted or updated for G Medical Innovations (GMVDF)?
There is no next analyst rating for G Medical Innovations.
Is the Analyst Rating G Medical Innovations (GMVDF) correct?
There is no next analyst rating for G Medical Innovations.
Browse analyst ratings and price targets on all stocks.